Skip to main content
OpenTrials

Clinical trial condition

Recurrent Childhood Rhabdomyosarcoma

Explore clinical trials studying Recurrent Childhood Rhabdomyosarcoma. Study availability and eligibility vary by location and protocol.

30 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Childhood Rhabdomyosarcoma trial results

Completed

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

NCT01305200

Conditions
Bone Marrow Diseases, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, +89 more
Locations
  • Children's Oncology Group Arcadia, California, United States
  • City of Hope Duarte, California, United States
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Rady Children's Hospital - San Diego San Diego, California, United States
View all 35 locations
View Trial Details
Completed

Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

NCT01614795

Conditions
Childhood Alveolar Soft Part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, +34 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 76 locations
View Trial Details
Completed

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

NCT00070109

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +17 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Children's Hospital Central California Madera, California, United States
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 14 locations
View Trial Details
Completed

Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer

NCT01502410

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 92 locations
View Trial Details
Completed

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

NCT00309907

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +86 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Oncology Group Arcadia, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 26 locations
View Trial Details
Completed

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

NCT01222715

Conditions
Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma, Childhood Pleomorphic Rhabdomyosarcoma, +11 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 184 locations
View Trial Details

Related conditions